MSF Scientific Days International 2024, London

MSF Scientific Days International 2024, London, UK
On May 16, a diverse group of people from within and outside Médecins Sans Frontières (MSF) gathered at the British Medical Association in London. This event, an annual “conference without borders,” also welcomed online participants from over 100 countries. The focus was on showcasing medical research in fragile and conflict-affected settings.

Often, the populations MSF serves are excluded from the benefits of research despite being among those who need it the most. Speakers at the conference discussed how MSF’s research influences the delivery of care in their projects, highlighted knowledge gaps that can affect political decisions and humanitarian responses, and identified best practices and funding innovations crucial for enhancing MSF’s capacity to act.

The presentations covered topics such as infectious diseases, outbreaks, vaccinations, and mortality assessment in crisis settings. Notably, Prof. Ahmed Fahal, Director of the Mycetoma Research Center at the University of Khartoum, presented the results of the Once-weekly repurposed fosravuconazole versus daily itraconazole, with surgery, in patients with eumycetoma in Sudan: a randomised, double-blind, phase 2, proof-of-concept superiority trial.
Fahal AH, Ahmed ES, Bakhiet SM, Bakheet OE, Fahal LA, Mohamed AA, Mohhamedelamin ESW, Bahar ME, Attalla HY, Siddig EE, Mahmoud NA, Musa AM, van de Sande WWJ, Scherrer B, Oyieko P, Egondi T, Onyango K, Hata K, Chu WY, Dorlo TPC, Nyaoke BA, Strub-Wourgaft N, Zijlstra EE.